Primary Graft Failure after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies

Clinical outcomes after primary graft failure (PGF) remain poor. Here we present a large retrospective analysis (n=23,272) which investigates means to prevent PGF and early detection of patients at high risk. In patients with hematologic malignancies, who underwent their first myeloablative allogene...

Descripción completa

Detalles Bibliográficos
Autores principales: Olsson, Richard F., Logan, Brent R., Chaudhury, Sonali, Zhu, Xiaochun, Akpek, Görgün, Bolwell, Brian J., Bredeson, Christopher N., Dvorak, Christopher C., Gupta, Vikas, Ho, Vincent T., Lazarus, Hillard M., Marks, David I., Ringdén, Olle T.H., Pasquini, Marcelo C., Schriber, Jeffrey R., Cooke, Kenneth R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527886/
https://www.ncbi.nlm.nih.gov/pubmed/25772027
http://dx.doi.org/10.1038/leu.2015.75

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527886/
https://www.ncbi.nlm.nih.gov/pubmed/25772027
http://dx.doi.org/10.1038/leu.2015.75

Ejemplares similares